Data Acknowledgements

Alzheimer’s Disease (AD)

Unlearn’s AD DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

Data used in preparation of this project were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found here. The ADNI was launched in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). For up-to-date information, see www.adni-info.org.

Amyotrophic Lateral Sclerosis (ALS)

Unlearn’s ALS DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

Data used in the preparation of this project were obtained from the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database. As such, the following organizations and individuals within the PRO-ACT Consortium contributed to the design and implementation of the PRO-ACT Database and/or provided data, but did not participate in the analysis of the data or the writing of this report: ALS Therapy Alliance, Cytokinetics, Inc., Amylyx Pharmaceuticals, Inc., Knopp Biosciences, Neuraltus Pharmaceuticals, Inc., Neurological Clinical Research Institute, MGH; Northeast ALS Consortium; Novartis; Prize4Life Israel; Regeneron Pharmaceuticals, Inc.; Sanofi; Teva Pharmaceutical Industries, Ltd., The ALS Association. In 2011, Prize4Life, in collaboration with the Northeast ALS Consortium, and with funding from the ALS Therapy Alliance, formed the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Consortium. The data available in the PRO-ACT Database has been volunteered by PRO-ACT Consortium members.

Atopic Dermatitis (AtD)

Data used in this indication do not require acknowledgements.

Crohn’s Disease (CD)

Unlearn’s CD DTG was trained and tested based on data obtained from the IBD Plexus program of the Crohn’s & Colitis Foundation.

Dyslipidemia (DLD)

Unlearn’s DLD DTG was trained and tested based on data from the ALLHAT, BARI2D, GHCoE-New Delhi, ICARE, LRC-CCPT, MEDFOCUS, MRFIT, POWERUP, PROMISE, and SNAP studies. Research Materials were obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and do not necessarily reflect the opinions or views of the aforementioned studies.

Frontotemporal Dementia (FTD)

Unlearn’s FTD DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

Data used in preparation of this project were obtained from the National Alzheimer’s Coordinating Center (NACC). The NACC database is funded by NIA/NIH Grant U24 AG072122.

Huntington’s Disease (HD)

Unlearn’s HD DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

Data used in this work was generously provided by the participants in PREDICT-HD and made available by the PREDICT-HD Investigators and Coordinators of the Huntington Study Group, Jane Paulsen, Principal Investigator. PREDICT-HD was funded by the National Institute of Health (NIH) under Grant# NS040068.

Hypertension (HTN)

Unlearn’s HTN DTG was trained and tested based on data from the AIM-HIGH, ALLHAT, BARI2D, CHOICES, GHCoE-New Delhi, HHL, ICARE, IDEA, LRC-CCPT, MEDFOCUS, MRFIT, POWERUP, PROMISE, SHEP, SNAP, and TOHP studies. Research Materials were obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and do not necessarily reflect the opinions or views of the aforementioned studies.

Major Depressive Disorder (MDD)

Unlearn’s MDD DTG was trained and tested based on data obtained from sources that are acknowledged below:

Data and/or research tools used in the preparation of this document were obtained from the National Institute of Mental Health (NIMH) Data Archive (NDA).

Parkinson’s Disease (PD)

Unlearn’s PD DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

This research is based on the National Institute of Neurologic Disease and Stroke (NINDS) data received from the Archived Clinical Research Dataset website. The original study PI’s and primary study publications are acknowledged below:

  1. Moore CG, Schenkman M, et al. Study in Parkinson disease of exercise (SPARX)...
  2. Parkinson Study Group SURE-PD Investigators; Schwarzschild MA, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol...
  3. Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease...
  4. Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease...
  5. Parkinson Study Group. A Controlled Trial of Rasagiline in Early Parkinson Disease: The TEMPO Study...

Psoriasis (PsO)

Data used in this indication do not require acknowledgements.

Rheumatoid Arthritis (RA)

Data used in this indication do not require acknowledgements.

Schizophrenia (SCZ)

Unlearn’s SCZ DTG was trained and tested based on data obtained from sources that are acknowledged below:

Data and/or research tools used in the preparation of this document were obtained from the National Institute of Mental Health (NIMH) Data Archive (NDA).

Stroke (STR)

Unlearn’s STR DTG was trained and tested based on data obtained from multiple sources. The text below acknowledges data contributions from certain providers.

This research is based on the National Institute of Neurologic Disease and Stroke (NINDS) data received from the Archived Clinical Research Dataset website.

Type 2 Diabetes (T2D)

Unlearn’s T2D DTG was trained and tested based on data from the AIM-HIGH, ALLHAT, BARI2D, GHCoE-New Delhi, HHL, ICARE, MEDFOCUS, MRFIT, POWERUP, and PROMISE studies. Research Materials were obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and do not necessarily reflect the opinions or views of the aforementioned studies.